GlassScriptPhysician profile
Sharon Reynolds
NPI 1821563768
$1,781.96
in general payments reported to CMS, 2019-2025
25 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $331 · 2023: $380 · 2024: $400 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $656.87 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $134.75 | 2022-2025 | Xtandi, Padcev |
| Endo USA, INC. | $122.73 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $93.95 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $91.58 | 2022-2024 | Aveed, Xiaflex, Edex |
| Abbvie INC. | $86.68 | 2022-2025 | |
| Amgen INC. | $65.00 | 2021 | |
| Progenics Pharmaceuticals, INC. | $61.14 | 2022-2024 | Pylarify |
| Janssen Biotech, INC. | $52.17 | 2025 | Erleada |
| Urovant Sciences INC | $45.24 | 2022 | |
| Antares Pharma, INC. | $43.75 | 2022 | |
| Myovant Sciences INC. | $39.03 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $38.49 | 2023 | Imbruvica |
| Biodelivery Sciences International, INC. | $37.77 | 2021 | |
| Innovation Technologies INC | $23.83 | 2023 | Irrisept |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $23.09 | 2025 | Gentlecath Glide |
| Incyte Corporation | $21.40 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.17 | 2022 | |
| Myriad Genetic Laboratories, INC. | $20.30 | 2024 | Prolaris |
| Arbor Pharmaceuticals, INC. | $20.26 | 2021 | |
| Collegium Pharmaceutical, INC. | $18.35 | 2021 | |
| Deciphera Pharmaceuticals INC. | $17.44 | 2021 | |
| Pfizer INC. | $16.76 | 2025 | |
| Genzyme Corporation | $16.72 | 2024 | |
| Celgene Corporation | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.